These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1490746)

  • 21. Diagnosis and management of urinary tract infections in the outpatient setting: a review.
    Grigoryan L; Trautner BW; Gupta K
    JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of recurrent urinary tract infections in women.
    Stamm WE; McKevitt M; Roberts PL; White NJ
    Rev Infect Dis; 1991; 13(1):77-84. PubMed ID: 2017637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. French consensus on antibiotherapy of urinary tract infections. The French Society for Infectious Diseases.
    Humbert G
    Infection; 1992; 20 Suppl 3():S171-2. PubMed ID: 1490744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urinary tract infections. Recommendations with special emphasis on family practice].
    Hovig B
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):44-6. PubMed ID: 8435104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent urinary tract infection in adult women: diagnosis and treatment.
    Nicolle LE; Ronald AR
    Infect Dis Clin North Am; 1987 Dec; 1(4):793-806. PubMed ID: 3333659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urinary tract infections in women--possibilities of differentiated approach in treatment and prevention].
    Kladenský J
    Ceska Gynekol; 2012 Feb; 77(1):5-9. PubMed ID: 22536633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial.
    Stamm WE; Counts GW; Wagner KF; Martin D; Gregory D; McKevitt M; Turck M; Holmes KK
    Ann Intern Med; 1980 Jun; 92(6):770-5. PubMed ID: 6992677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of recurrent urinary tract infections.
    Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
    Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial agents for treating uncomplicated urinary tract infection in women.
    Zalmanovici Trestioreanu A; Green H; Paul M; Yaphe J; Leibovici L
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007182. PubMed ID: 20927755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Best pharmacological practice: urinary tract infections.
    Nicolle L
    Expert Opin Pharmacother; 2003 May; 4(5):693-704. PubMed ID: 12739995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial agents in urinary tract infections.
    Wilhelm MP; Edson RS
    Mayo Clin Proc; 1987 Nov; 62(11):1025-31. PubMed ID: 3312853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No. 250-Recurrent Urinary Tract Infection.
    Epp A; Larochelle A
    J Obstet Gynaecol Can; 2017 Oct; 39(10):e422-e431. PubMed ID: 28935065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis].
    Ludwig M; Hoyme U; Weidner W
    Urologe A; 2006 Apr; 45(4):436-42. PubMed ID: 16489444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience.
    Alexiou Z; Mouktaroudi M; Koratzanis G; Papadopoulos A; Kavatha D; Kanellakopoulou K; Giamarellou H; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2007 Jul; 30(1):40-3. PubMed ID: 17459663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole.
    Harding GK; Buckwold FJ; Marrie TJ; Thompson L; Light RB; Ronald AR
    JAMA; 1979 Nov; 242(18):1975-7. PubMed ID: 480642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for preventing recurrent urinary tract infection during pregnancy.
    Schneeberger C; Geerlings SE; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009279. PubMed ID: 23152271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies.
    Geerlings SE; Beerepoot MA; Prins JM
    Infect Dis Clin North Am; 2014 Mar; 28(1):135-47. PubMed ID: 24484580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic urinary tract infection among pregnant women receiving ante-natal care in a traditional birth home in Benin City, Nigeria.
    Oladeinde BH; Omoregie R; Oladeinde OB
    Ethiop J Health Sci; 2015 Jan; 25(1):3-8. PubMed ID: 25733779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.